Repligen Corporation (RGEN) stock analysis
In our weekly check, Repligen Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 6.
About Repligen Corporation
Repligen Corporation is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as RGEN.
What our checks show for RGEN
Red flags
- The net margin fell by 20.6 points over 5 years, to -1.5%: the company keeps less of each sale as profit.
- The gross margin fell by 7.3 points, to 51.1%: costs are rising faster than prices.
- Earnings per share fell 60.3% a year over the last 3 years.
- The company is losing money: the net margin is -1.5%.
- The stock has fallen as much as 68% from a peak. Would you have held through that?
- Return on capital (ROCE) is only 0.7%.
Warning signs
- Revenue grew only 0.2% a year over the last 3 years.
- The price swings a lot: 46.2% annual volatility. Expect large ups and downs.
- The stock is still below its previous peak.
- Pay in shares equals 31.7% of free cash flow: it dilutes shareholders.
Strengths
- Debt is low: 0.33x equity.
- Operating profit covers interest 49.4 times over.
- Operating cash flow is 11x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 245% a year over the next years.
- Analysts expect revenue to grow about 20.8% a year over the next years.
- Analysts expect the net margin to improve by 19.1 points from today's -1.5%.
Similar companies
AVTR · COO · ATR · BAX · SOLV · BLCO
Questions
What grade does Repligen Corporation (RGEN) have?
In our weekly check, Repligen Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 6. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of RGEN stock?
This week's biggest flags for Repligen Corporation: Margins falling, Gross margin falling, Weak EPS growth. In total 10 of 22 checks show a warning or a red flag.
What does Repligen Corporation do?
Repligen Corporation is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as RGEN.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis